# Quality Score Report: Barrier 4 Cross-Pollination Synthesis (TASK-015)

> adv-scorer | S-014 LLM-as-Judge | I1 | PROJ-014 | 2026-02-28

## L0 Executive Summary

**Score:** 0.930/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Evidence Quality (0.88)
**One-line assessment:** The synthesis is structurally sound and intellectually rigorous — all 6 cross-cutting themes are well-grounded, all 3 GC-P4 gate checks pass, and dependency mapping is precise — but it cannot reach 0.95 due to an unresolved TASK-014 recommendation count discrepancy (~16 stated vs. ~13 actual), a self-assessment confidence table that self-scores at 0.955 without independent verification, and minor evidence tier gaps in how the TASK-013 A-11 hallucination impacts the downstream evidence status of NPT-008.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/barrier-4/synthesis.md`
- **Deliverable Type:** Cross-Pollination Synthesis (Barrier 4)
- **Criticality Level:** C4
- **Quality Threshold:** >= 0.95 (orchestration directive)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Iteration:** I1 (first scoring pass)
- **Scored:** 2026-02-28

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.930 |
| **Threshold** | 0.95 (C4 orchestration directive) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No — I1 standalone scoring |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.95 | 0.190 | All 5 analyses represented; 8 upstream sources cataloged; all 6 required synthesis elements present; recommendation count uncertainty for TASK-014 is disclosed |
| Internal Consistency | 0.20 | 0.92 | 0.184 | No inter-analysis contradictions; GC-P4 constraints consistent throughout; self-assessment scores (0.955) slightly inconsistent with disclosed uncertainties |
| Methodological Rigor | 0.20 | 0.95 | 0.190 | Deductive cross-pollination framework applied; NPT applicability convergence matrix constructed; dependency map grounded in textual citations; 6 gaps consolidated with frequency-weighted prioritization |
| Evidence Quality | 0.15 | 0.88 | 0.132 | Evidence tiers correctly propagated for 5 of 6 themes; T4 vs. T1+T3 distinction rigorously maintained; A-11 hallucination disclosed and propagation rule stated; NPT-008 evidence consequence not fully propagated through Group 2 recommendations |
| Actionability | 0.15 | 0.95 | 0.143 | 4 ADR scopes defined with decision points; Group 1/2/3 priority unambiguous; implementation sequence explicit; Phase 2 gate constraint stated prominently |
| Traceability | 0.10 | 0.92 | 0.092 | Most claims traceable to specific Rec-IDs; source summary table complete with per-analysis quality scores; TASK-014 "~16" count lacks specific Rec-ID enumeration |
| **TOTAL** | **1.00** | | **0.931** | |

**Arithmetic verification:**
- Completeness: 0.95 × 0.20 = 0.190
- Internal Consistency: 0.92 × 0.20 = 0.184
- Methodological Rigor: 0.95 × 0.20 = 0.190
- Evidence Quality: 0.88 × 0.15 = 0.132
- Actionability: 0.95 × 0.15 = 0.1425
- Traceability: 0.92 × 0.10 = 0.092
- **Composite: 0.190 + 0.184 + 0.190 + 0.132 + 0.1425 + 0.092 = 0.9305 (rounded to 0.931)**

Note: The report header states 0.930 (truncated to 3 decimal places).

---

## Detailed Dimension Analysis

### Completeness (0.95/1.00)

**Evidence:**

All six required synthesis elements are present and substantive:

1. **Cross-cutting themes (Section 2):** Six themes identified, each verified across multiple analyses with source citations. Theme 1 (NPT-009 universal upgrade target) confirmed in all 5 analyses with per-analysis evidence tables. Theme 5 (PG-003 universality) confirmed with "Divergence from convergence — none found" statement.

2. **Recommendation dependency map (Section 3):** Four intra-domain dependencies (TASK-012→TASK-011, TASK-012→TASK-010, TASK-011 schema, TASK-014→WTI) and two independence declarations. Conflict identification explicitly states "No direct conflicts identified."

3. **Consolidated implementation priority (Section 4):** Three groups with counts (~20, ~62, ~27 totaling ~109) and evidence tier classification. Per-group tables reference source Rec-IDs.

4. **Phase 5 ADR inputs (Section 5):** Four ADR scopes with evidence base per ADR, decision points, and primary input analysis attribution.

5. **Evidence gap consolidation (Section 6):** Six cross-analysis gaps (GAP-X1 through GAP-X6) with frequency counts and A-11 citation resolution documented.

6. **Constraint propagation verification (Section 7):** GC-P4-1, GC-P4-2, GC-P4-3 each verified per-analysis with compliance status.

**Gaps:**

- TASK-014 recommendation count stated as "approximately 16" in the L0 summary and ~16 in the source summary table. Direct count from TASK-014 document produces 13 named recommendations (ADV-REC-001 through ADV-REC-003 = 3; WT-REC-001 through WT-REC-004 = 4; DT-REC-001, DT-REC-002, DT-REC-003 BLOCKED = 3; REQ-REC-001 through REQ-REC-003 = 3; total = 13, of which 12 are actionable and 1 BLOCKED). The synthesis states "~16" without documenting the gap between 13 confirmed and ~16 estimated. This is appropriately disclosed as approximate (0.85 confidence note) but the discrepancy is not explained.

- The NPT applicability convergence matrix (Section L1, lines 88-97) presents TASK-013 as "NO" for NPT-013. This is correct per TASK-013 (NPT-013 is out of scope for pattern catalog files), but the synthesis does not explain why — a reader would need to go back to TASK-013 to understand. A one-sentence justification would eliminate this opacity.

**Improvement Path:**

Count TASK-014 Rec-IDs explicitly (the document is readable) and state the actual count. If the ~16 figure was intended to include sub-items within recommendations (WT-REC-002 covers 4 templates, WT-REC-004 covers 6 templates), document that counting methodology. Replace "~16" with a bounded range (e.g., "13 named recommendations, covering 19 total template modifications").

---

### Internal Consistency (0.92/1.00)

**Evidence:**

The synthesis maintains strong internal consistency across its core claims:

- Recommendation counts: TASK-010 (37), TASK-011 (32), TASK-012 (14), TASK-013 (34) are stated consistently in the L1 recommendation count table, Section 4 consolidated priority, and the source summary. These match the source analyses.

- Group totals: Group 1 (~20) + Group 2 (~62) + Group 3 (~27) = ~109. This matches the L0 total claim of "109 specific recommendations."

- GC-P4 verdicts: All three are PASS throughout Sections 7, the self-review checklist, and the source summary column. No inconsistency detected.

- NPT-012 scoping: Stated consistently in L1 (lines 94-98), Section 2 Theme 1 implicit, Section 5 ADR-004. The constraint "NPT-012 excluded from skill and agent scope" is not contradicted anywhere.

- Phase 2 gate: All five analyses are described as unanimous on the Phase 2 gate constraint. Section 3 dependency map quotes each analysis's specific language.

**Gaps:**

- The PS Integration confidence table (Section 8) self-assigns a weighted composite of 0.955 — above the 0.95 threshold, constituting a PASS self-assessment. However, the same section discloses the following uncertainties: TASK-014 recommendation count confidence at 0.85; ADR scope inference confidence at 0.88; dependency map confidence at 0.90. If these dimensions were scored independently against a rubric (as S-014 requires), a composite of 0.955 would be inconsistent with two dimensions below 0.90. A scorer applying anti-leniency rules would compute a lower composite from those dimension scores. The self-assessment appears inflated relative to the disclosed confidence levels.

- Section 4 Group 2 states "~62 specific recommendations" but the per-row tables aggregate counts informally. The 62 figure is not independently derivable from the displayed rows without summing across the 7 entries. A cross-check from the input analyses (TASK-010 Group 2 recs = ~26, TASK-011 Group 2 = 27, TASK-012 Group 2 = 6, TASK-013 Group 2 = 18, TASK-014 Group 2 = ~5) yields ~82, not 62. This is a significant internal discrepancy that undermines the Group 2 count.

**Improvement Path:**

1. Revise the PS Integration self-assessment composite downward to be consistent with the dimension scores disclosed, or document explicitly that the 0.955 reflects a different scoring methodology than S-014.
2. Audit the Group 2 total (~62) against per-analysis Group 2 counts from each source analysis. TASK-011 contributes 27 agent-level recommendations to Group 2; TASK-013 contributes 18. These two alone total 45, suggesting the ~62 figure may be plausible but requires explicit arithmetic to verify.

---

### Methodological Rigor (0.95/1.00)

**Evidence:**

The cross-pollination methodology is systematic and documented:

- **Framework declaration:** The synthesis references a "deductive cross-pollination framework" per Braun & Clarke. The self-review checklist confirms this framework was applied.

- **Evidence framework inheritance:** Section L1 explicitly documents that all five analyses draw from the same upstream framework (NPT-001 through NPT-014, PG-001 through PG-005, VS-001 through VS-004, AGREE-5 hierarchy) — meaning disagreements between analyses are domain-specific rather than epistemic. This is a rigorous framing observation.

- **NPT applicability convergence matrix:** The 7-row × 5-column matrix (Section L1, lines 88-97) systematically maps each relevant NPT pattern against all five domain analyses. This is the right structure for cross-pollination at this scale.

- **Maturity stack architecture:** Section L2 constructs a three-tier maturity observation across all five domains — high/mid/low maturity correlating with domain specificity and operational risk. The T4 observational label is correctly applied.

- **Dependency identification:** The dependency map in Section 3 identifies relationships using explicit textual evidence from each analysis rather than synthesizer inference. The "no direct conflicts" conclusion is explicitly verified rather than assumed.

- **Gap frequency weighting:** Section 6 elevates gaps that appear across multiple analyses as higher priority. GAP-X1 (all 5 analyses) and GAP-X2 (4 of 5) correctly receive the highest priority designation.

**Gaps:**

- The "6 cross-cutting themes" count is stated as an established finding, but the methodology for determining when something qualifies as "cross-cutting" (3+ analyses? all 5?) is not explicitly stated. Theme 3 (NPT-013 constitutional triplet) appears in only 3 of 5 analyses, while Theme 1 appears in all 5. The distinction between "cross-cutting" (3+) and "universal" (all 5) is implicit rather than explicit.

- The maturity stack observation (Section L2) correctly labels itself T4 observational but does not apply the "NEVER treat as causal" caveat as prominently as the same observation receives in the individual analyses. The synthesis propagates this finding but slightly softens the epistemic constraint.

**Improvement Path:**

Add one sentence to Section 2's introduction defining the cross-cutting threshold (e.g., "A theme qualifies as cross-cutting if it appears in 3 or more of the 5 analyses; themes appearing in all 5 are marked 'universal'"). This makes the classification methodology explicit for downstream Phase 5 users.

---

### Evidence Quality (0.88/1.00)

**Evidence:**

The synthesis correctly propagates most evidence tier designations from the input analyses:

- T1+T3 vs. T4 distinction is maintained throughout. Group 1 (NPT-014 elimination) is correctly labeled T1+T3 unconditional; Groups 2 and 3 are correctly labeled T4 observational with Phase 2 contingency.

- A-11 citation hallucination is documented in Section 6 with a forward propagation rule ("NEVER cite A-11 in any Phase 5 document"). The evidence implication — NPT-008 evidence reduced to E-007 (AGREE-9, moderate cross-survey) — is documented.

- VS-001 through VS-004 evidence is preserved with the Anthropic-heavy concentration caveat (Section 6 evidence table).

- The three competing causal explanations for VS-002 are preserved as "ambiguity preserved; not collapsed to single explanation."

**Gaps:**

The A-11 resolution documentation in Section 6 states that NPT-008 evidence "now rests exclusively on E-007 (AGREE-9 moderate cross-survey agreement)" and correctly labels this as "T4, AGREE-9 cross-survey agreement, moderate confidence." However, Section 4's Group 2 recommendation table includes "WT-REC-002 (upgrade BAD/GOOD to NPT-009)" from TASK-014 — this recommendation upgrades the worktracker contrastive examples from NPT-008 to NPT-009. The primary driver for NPT-009 preference over NPT-008 partially rests on E-007 (the AGREE-5 hierarchy rank ordering). With A-11 removed, the specific AGREE-5 rank advantage of NPT-009 over NPT-008 now rests on weaker evidence than when A-11 was cited. The synthesis does not propagate this weakening to the specific Group 2 recommendations that would be most affected.

Second gap: The synthesis states TASK-014's "~16 recommendations" without being able to verify this count from evidence. The evidence for this figure (0.85 confidence) is the lowest evidential claim in the synthesis. At C4 threshold (0.95), a significant count uncertainty in one of five inputs is a meaningful quality gap.

Third gap: The "AGREE-5 hierarchy" is noted consistently as "internally generated synthesis narrative (passed adversary gate 0.953, NOT externally validated)." This caveat appears in Section L1. However, Section 4's Group priority classifications and Section 5's ADR inputs use AGREE-5 hierarchy rankings to justify NPT upgrade priorities without re-surfacing this caveat. Phase 5 ADR writers could pick up Group 2 recommendations from Section 4 without encountering the AGREE-5 provenance warning unless they cross-reference Section L1.

**Improvement Path:**

1. Add a note to Group 2 in Section 4 that recommendations whose priority depends on AGREE-5 rank ordering carry the internal-synthesis caveat (AGREE-5 is NOT externally validated). One sentence is sufficient.
2. Propagate the A-11 weakening explicitly to WT-REC-002 and any other recommendation that motivates NPT-008→NPT-009 upgrades via the AGREE-5 rank ordering. State: "WT-REC-002 evidence: NPT-008→NPT-009 upgrade is motivated by AGREE-5 rank preference (NPT-009 at rank 9 vs NPT-008 at rank 10-11). A-11 citation was removed in TASK-013 I5; rank ordering now rests on E-007 only (AGREE-9, moderate cross-survey)."

---

### Actionability (0.95/1.00)

**Evidence:**

The synthesis provides clear, specific, implementable guidance for Phase 5 ADR writers:

- **Four ADR scopes defined with decision points:** ADR-001 (NPT-014 elimination, unconditional) through ADR-004 (context compaction resilience) each have: scope statement, evidence base table (T1+T3 column, T4 column, gaps column), decision points (D-001 through D-006), and primary input analysis attribution. A Phase 5 ADR writer can start from Section 5 without reading all five input analyses.

- **Phase 2 gate is the single most critical ordering constraint** and is stated in at least four locations: L0 executive summary, Section 3 primary dependency, Section 4 Group 1 note, and Section 7 GC-P4-2 verification. No reader will miss this constraint.

- **Implementation sequence is unambiguous:** Group 1 (draft now, implement after Phase 2 baseline capture), Group 2 (draft contingent, implement after Phase 2), Group 3 (post-Phase 2, additional verification needed).

- **The one unconditional exception is clearly marked:** NPT-014 elimination is the only recommendation category that does not require Phase 2 completion before drafting. This is stated in the L0 summary, the dependency map, and Section 4.

- **TASK-013 independence finding** (patterns analysis is independent of all other 4) gives Phase 5 the option to parallelize patterns updates with rules/agents/skills updates. This is a practically valuable finding.

**Gaps:**

The ADR-002 decision points include "D-004: Whether structural refactor (eng-team/red-team flat markdown → XML-tagged) is in scope." This decision point requires input from TASK-011 (which identifies it as Group 3 optional). However, Section 5 does not explicitly link D-004 to Group 3 classification — a Phase 5 architect would need to cross-reference Section 4 to understand the priority. A one-line note would improve usability.

**Improvement Path:**

Add cross-references from ADR decision points to the Group classification in Section 4. For example: "D-004: structural refactor — classified Group 3 (MAY add, post-Phase 2) in Section 4."

---

### Traceability (0.92/1.00)

**Evidence:**

Traceability is strong across the main content sections:

- Section 2 theme tables cite specific analysis documents and Rec-IDs for every finding. Theme 1 (NPT-009 universality) provides a per-analysis findings table with specific counts and document section references.

- The source summary table (end of document) provides per-source: path, version, quality score, iteration count, key contribution, and cross-cutting theme mapping. This enables backward tracing from any theme to its contributing analyses.

- The cross-cutting convergence matrix (Section L1) is a single-table that traces every NPT pattern's applicability across all five domains. Phase 5 architects can verify any NPT scope claim against this table.

- GC-P4 verification tables (Section 7) cite specific quotes from each analysis supporting compliance. Each quote is attributable.

- A-11 resolution cites "I4 escalated, I5 confirmed via web search" — the chain of custody for the citation removal is documented.

**Gaps:**

The TASK-014 "~16 recommendations" figure in Section L1's recommendation count table is labeled as approximate and carries a 0.85 confidence note. However, the figure cannot be verified without reading TASK-014 in full and counting. When a downstream user needs to verify that all ~109 recommendations are accounted for, the ~16 figure is the weakest link in the traceability chain.

The dependency map section references "TASK-012 → TASK-011" and "TASK-012 → TASK-010" dependencies, citing specific analysis text as evidence. However, the source quotes for these dependencies are paraphrased rather than quoted. For C4 traceability, direct quotes would strengthen the dependency claims.

**Improvement Path:**

1. Replace the "~16" TASK-014 count with a verified count (count all explicitly named recommendations in TASK-014 by section). If the "~16" reflects sub-item counting methodology, document that explicitly.
2. For the two intra-domain dependencies in Section 3, add a direct quote from each source analysis (the same pattern used for Phase 2 gate quotes in the same section).

---

## Phase 4 Gate Checks

| Gate | Requirement | Status | Evidence |
|------|-------------|--------|---------|
| GC-P4-1 | Synthesis does NOT claim experimental validation | PASS | L0 mandatory constraint present; all 109 recommendations labeled T4 observational or T1+T3 (blunt prohibition only); self-review checklist confirms. No phrase "experimentally validated" applied to framing recommendations. |
| GC-P4-2 | Consolidated recommendations do NOT make Phase 2 conditions unreproducible | PASS | Section 3 primary dependency explicitly states all implementations are gated on Phase 2 completion; Group 1 "draft now, implement after baseline capture" distinction maintains Phase 2 reproducibility; all 5 per-analysis compliance statuses verified in Section 7. |
| GC-P4-3 | PG-003 contingency preserved through cross-pollination | PASS | PG-003 contingency applied to all Group 2 and Group 3 recommendations; "reversible under PG-003 null outcome" appears explicitly in Group 2 methodology; Section 7 verifies all 5 analyses have per-recommendation reversibility tags. |

**Overall gate assessment: All three GC-P4 gates PASS at synthesis level.** The cross-pollination did not create any new constraint violations that were absent from the individual analyses.

---

## Issues Found

### Issue 1: TASK-014 Recommendation Count Discrepancy (MEDIUM)

**Description:** The synthesis states "approximately 16 recommendations across 4 template families" for TASK-014. Direct count from TASK-014 produces 13 named recommendations (ADV-REC-001–003 = 3; WT-REC-001–004 = 4; DT-REC-001, DT-REC-002, DT-REC-003 BLOCKED = 3; REQ-REC-001–003 = 3; total = 13, of which 12 are actionable). The synthesis discloses the approximation and confidence level (0.85), but the gap between 13 confirmed and ~16 stated (a ~23% overcount) undermines the total of ~109 recommendations.

**Impact:** Traceability and Internal Consistency dimensions. If ~16 is actually ~13, the total moves from ~109 to ~106. This does not change analytical conclusions but weakens the quantitative claim in Phase 5 ADR inputs.

**Severity:** MEDIUM — affects count accuracy but not the analytical substance of any recommendation.

### Issue 2: Group 2 Total (~62) Not Verifiable from Displayed Data (MEDIUM)

**Description:** Section 4 Group 2 states "~62 specific recommendations." Cross-checking from input analyses: TASK-010 Group 2 = approximately 26 (13 NPT-013 recs + 5 NPT-010 recs + 8 other recs = ~26); TASK-011 Group 2 = 27 agent-level recs + 3 framework-level = 30; TASK-012 Group 2 = 6 (4 NPT-010 + 2 NPT-011); TASK-013 Group 2 = 18 SHOULD add; TASK-014 Group 2 = WT-REC-002, ADV-REC-001, WT-REC-003, ADV-REC-002, ADV-REC-003 = 5. Estimated total = 26+30+6+18+5 = 85, not 62. Either the counting methodology is different from summing Group 2 across all analyses (possible — some recs may span groups), or there is a miscalculation. The discrepancy cannot be resolved without explicit arithmetic.

**Impact:** Internal Consistency dimension. If Group 2 is actually ~85 rather than ~62, the consolidated priority structure shifts.

**Severity:** MEDIUM — the ~62 figure is used in the priority summary table that Phase 5 ADRs will reference.

### Issue 3: Self-Assessment Composite Inconsistent with Disclosed Confidence Levels (LOW)

**Description:** The PS Integration confidence table self-assigns 0.955 weighted composite. Key confidence disclosures in the same section: Completeness = 0.95, Internal Consistency = 0.96, Methodological Rigor = 0.95, Evidence Quality = 0.95, Actionability = 0.96, Traceability = 0.96. However, the synthesizer also discloses: TASK-014 count confidence = 0.85; ADR scope inference confidence = 0.88; cross-cutting theme identification = 0.92. These lower-confidence disclosures are not integrated into the dimension scores, suggesting the self-assessment inflated dimensions above what the disclosed uncertainties warrant.

**Impact:** Internal Consistency and meta-transparency. A downstream quality gate reviewer will notice the inconsistency between high per-dimension scores and lower cross-check confidence disclosures.

**Severity:** LOW — does not affect the synthesis content, only its self-assessment.

### Issue 4: A-11 Weakening Not Propagated to Group 2 Recommendations (LOW)

**Description:** Section 6 correctly documents that A-11 removal weakens NPT-008 evidence (now E-007 only, AGREE-9, moderate cross-survey). Section 4 Group 2 includes "WT-REC-002 (upgrade BAD/GOOD to NPT-009)" from TASK-014, which motivates the NPT-008→NPT-009 upgrade partly via AGREE-5 rank ordering. The synthesis does not note that this specific recommendation's evidence basis was affected by A-11 removal.

**Impact:** Evidence Quality dimension for NPT-008-related Group 2 recommendations.

**Severity:** LOW — the NPT-014→NPT-009 motivation for WT-REC-002 still holds (PG-001 unconditional applies to NPT-014 elimination; NPT-008→NPT-009 is a separate upgrade pathway that relies more on AGREE-5 rank ordering).

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Internal Consistency | 0.92 | 0.95 | Audit and correct Group 2 total (~62 stated; cross-analysis sum yields ~85). Either display explicit arithmetic or explain the counting methodology that produces 62. Correct the total and update the priority table accordingly. |
| 2 | Completeness | 0.95 | 0.96 | Count TASK-014 Rec-IDs explicitly (the file is readable). State "13 named recommendations (12 actionable, 1 BLOCKED for TDD.template.md)" rather than "~16." If sub-item counting was intended, document the methodology. |
| 3 | Evidence Quality | 0.88 | 0.92 | Add one sentence to Group 2 Section 4 noting that WT-REC-002 (NPT-008→NPT-009 upgrade) evidence was affected by A-11 removal: "Primary upgrade motivation for WT-REC-002 rests on E-007 (AGREE-9, moderate cross-survey) for the AGREE-5 rank ordering; NPT-014 elimination motivation remains T1+T3 unconditional per PG-001." |
| 4 | Traceability | 0.92 | 0.95 | Add direct quotes for the two intra-domain dependencies (TASK-012→TASK-011 and TASK-012→TASK-010) following the same format used for Phase 2 gate quotes. |
| 5 | Internal Consistency | 0.92 | 0.95 | Revise PS Integration self-assessment to align with disclosed confidence levels, or add an explanatory note that the dimension scores in the confidence table reflect a different dimension set than the S-014 rubric. |
| 6 | Methodological Rigor | 0.95 | 0.96 | Add one sentence defining the cross-cutting threshold: "A theme qualifies as cross-cutting if it appears in 3 or more of the 5 analyses; themes appearing in all 5 are marked 'universal.'" |

---

## Leniency Bias Check

- [x] Each dimension scored independently before weighted composite was computed
- [x] Evidence documented for each score — no score above 0.92 without direct document evidence
- [x] Uncertain scores resolved downward (Evidence Quality held at 0.88 despite disclosure of A-11 gap; Internal Consistency held at 0.92 despite strong structural performance)
- [x] Cross-pollination receives higher rigor standard than individual analyses — composite of 0.931 vs. input analyses at 0.950-0.955
- [x] Self-assessment composite (0.955) treated as suspect and scored lower than claimed
- [x] Group 2 count discrepancy (~62 stated vs. ~85 derived) flagged as Issue 2 rather than accepted at face value
- [x] TASK-014 approximate count (~16) investigated against actual Rec-ID count (found ~13) rather than accepted at stated value
- [x] No dimension scored above 0.95 without substantive specific evidence (Completeness and Methodological Rigor at 0.95; Actionability at 0.95)

**Anti-leniency note:** This synthesis is substantively strong. The three GC-P4 gates pass cleanly. The analytical depth across 6 themes, 4 ADR scopes, and 6 consolidated gaps is genuinely good work. The 0.931 composite reflects real quality that needs targeted precision fixes (count accuracy, evidence propagation) rather than substantive analytical gaps. Scoring it at 0.940+ would require accepting the self-assessment at face value — which S-014 prohibits.

---

## Session Context Handoff

```yaml
verdict: REVISE
composite_score: 0.931
threshold: 0.95
weakest_dimension: evidence_quality
weakest_score: 0.88
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "Audit and correct Group 2 total (stated ~62, cross-analysis derivation yields ~85); display explicit arithmetic"
  - "Count TASK-014 Rec-IDs explicitly (found ~13 actionable, not ~16); state precise count in L1 and source summary"
  - "Propagate A-11 weakening to WT-REC-002 evidence note in Group 2; cite E-007 explicitly for NPT-008 rank ordering claims"
  - "Add direct quotes for TASK-012->TASK-011 and TASK-012->TASK-010 dependency claims"
  - "Revise PS Integration self-assessment to align with disclosed cross-check confidence levels (0.85, 0.88, 0.92)"
  - "Define cross-cutting threshold explicitly in Section 2 introduction"
delta_from_prior: null
```

---

*Scored by: adv-scorer*
*Task: TASK-015 Quality Gate I1*
*Deliverable: barrier-4/synthesis.md v1.0.0*
*Scoring threshold: 0.95 (C4 orchestration directive)*
*Constitutional compliance: P-003 (no subagents invoked), P-020 (user authority preserved), P-022 (no score inflation)*
*SSOT: .context/rules/quality-enforcement.md*
*Created: 2026-02-28*
